In this episode, hosts Drs. Peter Lu and Temara Hajjat talk to Dr. Jean Molleston about drug-induced liver injury (DILI) in children.  Dr. Molleston is the former Division Chief of Gastroenterology, Hepatology, and Nutrition at Riley Children's and Professor of Clinical Pediatrics at University of Indiana School of Medicine.

Learning Objectives:

1. Understand the definition of DILI and signs that should raise our concern for this diagnosis.
2. Recognize common causes of DILI, including both medications and supplements.
3. Recognize the signs of drug reaction with eosinophilia and systemic symptoms or DRESS syndrome.

Links:

LiverTox: Searchable resource on drug-induced liver injury

Support the show

This episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode, hosts Drs. Temara Hajjat and Jenn Lee talk to Drs. Glenn Furuta and Noam Zevit about the diagnosis and management of eosinophilic GI disorders (EGIDs) beyond eosinophilic esophagitis based on the new joint ESPGHAN/NASPGHAN recommendations.

Learning Objectives:

• Discuss the diagnosis of non-EoE EGIDs.
• Explain the role of pathology in diagnosis of non-EoE EGIDs.
• Review management of non-EoE EGIDs.

References:

Joint ESPGHAN/NASPGHAN Guidelines on Childhood Eosinophilic GI Disorders Beyond Eosinophilic Esophagitis

Support the show

This episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode, hosts Drs. Temara Hajjat and Peter Lu  talk to Dr. Sean Moore about the impact of global health research on pediatric gastroenterology nationally and internationally.  Dr. Moore is a pediatric gastroenterologist and Division Head at Cincinnati Children's Hospital and Medical Center and a Professor of Pediatrics at University of Cincinnati School of Medicine.  

Learning Objectives:

1. Understand the value of global health research in pediatric GI.
2. Understand the impact of global health research on development of resources nationally and internationally. 
3. Recognize the approach to global health in pediatric GI.

Support the show

This episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode, hosts Drs. Peter Lu and Jason Silverman talk to Dr. Rima Fawaz about the role of GLP-1 receptor agonists in the treatment of children and adolescents with metabolic dysfunction-associated steatotic liver disease or MASLD (the artist formerly known as non-alcoholic fatty liver disease or NAFLD). We discuss what these medications do, what we know about their positive and negative effects, and how we should be using them based on the current literature. Dr. Fawaz is Medical Director of Pediatric Hepatology and Liver Transplantation at Yale New Haven Children's Hospital and Associate Professor at Yale School of Medicine.

Learning Objectives:

1. Understand the therapeutic and potential adverse effects of GLP-1 receptor agonists.
2. Recognize that the foundation of obesity and MASLD treatment remains lifestyle changes focused on diet and exercise.
3. Recognize the role that GLP-1 receptor agonists will play in our care for children and adolescents with obesity and MASLD.

Links:

Abou Jaoudeh RAR, et al. Pharmacological management of pediatric metabolic dysfunction-associated liver disaese. J Pediatr Gastroenterol Nutr. 2025.

Support the show

This episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this new episode Drs. Jason Silverman and Temara Hajjat sit down with Dr. Michael Dolinger to review intestinal ultrasound and how it will transform how we care for children with inflammatory bowel disease.

Michael Dolinger, MD, is the Director of Pediatric Inflammatory Bowel Disease and an Assistant Professor of Pediatrics at NYU Grossman School of Medicine. During his fellowship training, Dr. Dolinger became the first gastroenterology fellow in the United States to be trained and certified to perform intestinal ultrasound for inflammatory bowel disease activity monitoring. He has co-founded the Intestinal Ultrasound Group of the United States and Canada (iUSCAN) and now leads global training, education, and research efforts on the use of intestinal ultrasound as a non-invasive monitoring tool in inflammatory bowel disease care.

Learning objectives

1. Review the role for intestinal ultrasound in the diagnosis and monitoring of inflammatory bowel disease in children including its strengths and weaknesses.
2. Discuss the training path to certification in intestinal ultrasound.
3. Review strategies and considerations for integrating intestinal ultrasound into pediatric gastroenterology clinics.

Episode links

1. IUS as a pre-screening tool in clinical trials 
2. IUS guide to billing and credentialing 
3. IUS to predict endoscopic healing in children with CD
4. iUSscan.org

Support the show

This episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode, hosts Drs. Temara Hajjat and Jenn Lee talk to Dr. Rachel Chevalier. Dr. Chevalier is a pediatric gastroenterologist and physician scientist at Children's Mecy Hospital. She is an Associate Professor at the University of Missouri-Kansas City School of Medicine. In this episode, we’ll explore treatment options for eosinophilic esophagitis, discuss steroid complications and emerging therapies, and dive into the role of drug metabolism and genetics in optimizing patient care. 

Learning Objectives:

• Discuss available corticosteroid options, dosing strategies, administration techniques, and challenges like insurance coverage and FDA limitations.
• Highlight potential complications of steroid use, mitigation strategies, and emerging treatments like orodispersible tablets.
• Explain the role of CYP enzymes, genetic variability, and personalized approaches to optimize treatment based on Dr. Rachel Chevalier’s research.

Support the show

This episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode, hosts Drs. Temara Hajjat and Jenn Lee talk to Dr. David Vitale about EUS and ERCP indications in patients with acute pancreatitis and pancreatitis complications. Dr. Vitale is a pediatric gastroenterologist, the director of the interventional endoscopy center at Cincinnati Children's Hospital and Medical Center, and an Assistant Professor at the University of Cincinnati School of Medicine.  

Learning Objectives:

1. Understanding the indications of ERCP and EUS in acute pancreatitis 
2. Understand the indications of ERCP and EUS in pancreatitis complications 
3. Recognize the possible risks of EUS and ECRP in children

Support the show

This episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode, hosts Drs. Jason Silverman and Peter Lu sit down with Dr. Vicky Ng to discuss outcomes following pediatric liver transplantation beyond survival. In particular, we review the importance of hearing the patient voice using the PeLTQL, a disease-specific health related quality of life instrument.

Dr. Ng is a Professor of Pediatrics at the University of Toronto, Medical Director of the Paediatric Liver Transplantation Transplant and Regenerative Medicine Centre at SickKids Hospital and current President of NASPGHAN.

Learning objectives:

1. To understand the benefits of developing a condition-specific health-related quality of life (HRQOL) tool using the Pediatric Liver Transplantation Quality of Life questionnaire (PeLTQL) as a model.
2. To review pre- and post-transplant factors that may impact the HRQOL of pediatric liver transplant recipients.
3. To explore the benefits of the patient (and caregiver) voices in truly understanding important patient outcomes.

Links:

1. Development and Validation of the Pediatric Liver Transplantation Quality of Life: A Disease-Specific Quality of Life Measure for Pediatric Liver Transplant Recipients
2. Barriers to ideal outcomes after pediatric liver transplantation
3. Feasibility of using a patient-reported outcome measure into
   clinical practice following pediatric liver transplantation: The
   Starzl Network experience
4. Jennifer Vittorio - Healthcare Transitions in Pediatric Liver Transplantation (Special JPGN Episode) - Position paper

Support the show

This episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode, hosts Drs. Peter Lu and Jennifer Lee talk to Dr. Ann Ming Yeh about non-pharmacological treatment for children and adolescents with chronic abdominal pain and nausea, including lifestyle modification, herbal supplements, and acupuncture. Dr. Yeh is a pediatric gastroenterologist at Lucile Packard Children's Hospital and Clinical Professor at Stanford University.

Learning Objectives:

1. Understand the definition of integrative health.
2. Recognize herbal supplements that can help children with chronic abdominal pain and nausea.
3. Recognize the role of acupuncture for children with chronic abdominal pain and nausea.

Support the show

This episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.

In this episode, hosts Drs. Jason Silverman and Jennifer Lee sit down with Dr. Nikhil Pai on the early life development of the gut microbiome and its impacts on pediatric health and disease. Dr. Pai is an Associate Professor of Pediatrics at the Perelman School of Medicine and a pediatric gastroenterologist at the Children’s Hospital of Philadelphia.

Learning objectives:

1. To understand the early life influences on microbiome development.
2. To review the influence of our microbiome on various aspects of health and specific diseases.
3. To review various modalities for influencing the microbiome including prebiotics, probiotics, antibiotics and more. 

Links:

1. Season 2 Episode 24: Stacy Kahn - Fecal Microbiota Transplantation

Support the show

This episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!

As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.

Check out our merch website!

Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.

Click here to support the show.